New Leaf Venture Fund Overview and Performance Summary

New Leaf Venture Fund Overview and Performance Summary The document is a promotional summary of a venture capital fund with no mention of high‑profile public officials, financial misconduct, foreign influence, or actionable investigative leads. It contains only generic performance data and internal team descriptions, offering no novel or controversial information. Key insights: Describes Jim Niedel's role change to Venture Partner for NLV‑III.; Claims top‑quartile performance since mid‑1990s across multiple funds.; Notes $1.6 billion invested in healthcare technology since 1995.